Psoriasis News

  • ACR Subcutaneous Secukinumab Relieves Psoriatic Arthritis The interleukin-17A inhibitor is effective and safe, according to first results from the ongoing FUTURE5 study, the largest controlled trial of a biologic for psoriatic arthritis to date.
  • Psoriasis Tied to Higher Risk of Serious Liver Disease People with chronic inflammatory disorders like psoriasis and rheumatoid arthritis may have an increased risk of developing serious liver damage, a recent study suggests.

Psoriasis Perspective

  • Top News From ACR 2017: Slideshow A highly anticipated trial probing the benefit of stopping methotrexate for 2 weeks after flu vaccination to boost immune response in RA patients is among the meeting highlights.
  • Psoriatic Arthritis: Ruling Out the Mimics   Toronto specialists discuss the workup and differential diagnosis of PsA, as well as genetic markers that may indicate severe disease.